Zydus Lifesciences’ Desidustat Receives Approval from China’s NMPA
Zydus Lifesciences has received approval from China’s National Medical Products Administration (NMPA) for Desidustat tablets, indicated for the treatment of […]
NMPA-APPROVAL-CHINA
Zydus Secures First NMPA Approval in China for Venlafaxine Extended-Release Capsules
Indian origin pharmaceutical giant Zydus Lifesciences Limited has announced that it has received marketing authorisation from the National Medical Products […]
